Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir (Q42862277)

8 November 2017

title

Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir (English)

1 reference

8 November 2017

main subject

anti-retroviral agent

0 references

1 reference

Santosh Kumar

1

1 reference

8 November 2017

Ravinder Earla

2

1 reference

8 November 2017

Mengyao Jin

3

1 reference

8 November 2017

Anil Kumar

5

1 reference

8 November 2017

Ashim K. Mitra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20937259

31 July 2024

language of work or name

English

0 references

publication date

16 October 2010

1 reference

full work available at URL

8 November 2017

https://api.elsevier.com/content/article/PII:S0006291X10018656?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

https://api.elsevier.com/content/article/PII:S0006291X10018656?httpAccept=text/plain

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Biochemical and Biophysical Research Communications

31 July 2024

published in

1 reference

8 November 2017

volume

402

1 reference

8 November 2017

issue

1

1 reference

8 November 2017

page(s)

163-167

1 reference

Cytochromes P450 and metabolism of xenobiotics

8 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

The role of cytochrome P450 in antiretroviral drug interactions

31 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro

31 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

MDR- and CYP3A4-mediated drug-drug interactions

31 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Alcohol and medication interactions

31 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Pharmacokinetic interactions between alcohol and other drugs

31 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s

31 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages

31 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Antiretroviral therapy in macrophages: implication for HIV eradication

31 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Chemical properties of alcohols and their protein binding sites.

31 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Structural and dynamical basis of broad substrate specificity, catalytic mechanism, and inhibition of cytochrome P450 3A4.

31 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Allosteric mechanisms in cytochrome P450 3A4 studied by high-pressure spectroscopy: pivotal role of substrate-induced changes in the accessibility and degree of hydration of the heme pocket.

31 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

31 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

New prospects for nelfinavir in non-HIV-related diseases

31 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity

31 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics

31 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs

31 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Engineering of cytochrome P450 3A4 for enhanced peroxide-mediated substrate oxidation using directed evolution and site-directed mutagenesis.

31 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Effect of commonly used organic solvents on the kinetics of cytochrome P450 2B6- and 2C8-dependent activity in human liver microsomes

31 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Effects of organic solvents on the time-dependent inhibition of CYP3A4 by diazepam

31 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate

31 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19.

31 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities

31 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism

31 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Alcohol use can result in enhanced drug metabolism in HIV pharmacotherapy

31 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

HIV treatment in drug abusers: impact of alcohol use

31 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Evaluation of factors to decrease plasma concentration of an HIV protease inhibitor, saquinavir in ethanol-treated rats

31 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Alcohol use and HIV pharmacotherapy.

31 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS.

31 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.10.014

31 July 2024

Identifiers

1 reference

8 November 2017

1 reference